Trang Ho Thu Quach1,2,3, Nicholas Alexander Mallis1, José F Cordero4. 1. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, 30602, USA. 2. Institute for Global Health, College of Public Health, University of Georgia, Athens, GA, 30602, USA. 3. Faculty of Pharmacy, Ho Chi Minh City University of Technology (HUTECH), Ho Chi Minh City, Vietnam. 4. Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, 30602, USA. jcordero@uga.edu.
Abstract
OBJECTIVE: Pregnant women have a high risk for complications from influenza infection, but vaccination rates within this group remain low in the US and other countries. The efficacy and effectiveness of the influenza vaccine are a key determinant of vaccine uptake. This review aimed to synthesize the available evidence on the protection of both seasonal and monovalent pandemic H1N1 (pdmH1N1) vaccine against laboratory-confirmed influenza (LCI), influenza-like illness (ILI), and respiratory illness (RI). METHODS: A search of the literature was undertaken from Pubmed, Embase, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials up to Aug 1, 2018. Both observational studies and clinical trials were considered. RESULTS: Nineteen studies were identified from 11 countries. Women with pdmH1N1 vaccination had a lower risk of getting LCI (Relative risk [RR] 0.3, 95% confidence interval [CI] 0.26-0.35) and ILI (RR 0.15, 95% CI 0.06-0.36)). The pooled estimate from three randomized clinical trials (RR 0.47, 95% CI 0.31-0.71) and two case control studies (OR 0.37, 95% CI 0.23-0.61) showed that the seasonal vaccine was protective against LCI. The seasonal vaccine was not protective against ILI (RR 0.95, 95% CI 0.88-1.03). This association was similar for the outcome of RI (RR 0.81, 95% CI 0.55-1.20). CONCLUSION: This analysis bolsters existing evidence that influenza vaccines are effective among pregnant women. Additional public health efforts are needed to promote physician recommendations of influenza vaccination in pregnancy.
OBJECTIVE: Pregnant women have a high risk for complications from influenza infection, but vaccination rates within this group remain low in the US and other countries. The efficacy and effectiveness of the influenza vaccine are a key determinant of vaccine uptake. This review aimed to synthesize the available evidence on the protection of both seasonal and monovalent pandemic H1N1 (pdmH1N1) vaccine against laboratory-confirmed influenza (LCI), influenza-like illness (ILI), and respiratory illness (RI). METHODS: A search of the literature was undertaken from Pubmed, Embase, ClinicalTrials.gov, and Cochrane Central Register of Controlled Trials up to Aug 1, 2018. Both observational studies and clinical trials were considered. RESULTS: Nineteen studies were identified from 11 countries. Women with pdmH1N1 vaccination had a lower risk of getting LCI (Relative risk [RR] 0.3, 95% confidence interval [CI] 0.26-0.35) and ILI (RR 0.15, 95% CI 0.06-0.36)). The pooled estimate from three randomized clinical trials (RR 0.47, 95% CI 0.31-0.71) and two case control studies (OR 0.37, 95% CI 0.23-0.61) showed that the seasonal vaccine was protective against LCI. The seasonal vaccine was not protective against ILI (RR 0.95, 95% CI 0.88-1.03). This association was similar for the outcome of RI (RR 0.81, 95% CI 0.55-1.20). CONCLUSION: This analysis bolsters existing evidence that influenza vaccines are effective among pregnant women. Additional public health efforts are needed to promote physician recommendations of influenza vaccination in pregnancy.
Authors: Sascha R Ellington; Laura K Hartman; Meileen Acosta; Miguel Martinez-Romo; Lewis Rubinson; Denise J Jamieson; Janice Louie Journal: Am J Obstet Gynecol Date: 2011-04-22 Impact factor: 8.661
Authors: Mark G Thompson; De-Kun Li; Pat Shifflett; Leslie Z Sokolow; Jeannette R Ferber; Samantha Kurosky; Sam Bozeman; Sue B Reynolds; Roxana Odouli; Michelle L Henninger; Tia L Kauffman; Lyndsay A Avalos; Sarah Ball; Jennifer L Williams; Stephanie A Irving; David K Shay; Allison L Naleway Journal: Clin Infect Dis Date: 2013-11-26 Impact factor: 9.079
Authors: Gonçalo Matias; Robert Taylor; François Haguinet; Cynthia Schuck-Paim; Roger Lustig; Vivek Shinde Journal: BMC Public Health Date: 2017-03-21 Impact factor: 3.295